Gonadorelin vs kisspeptin-10
Gonadorelin is synthetic GnRH, acting directly on pituitary gonadotrophs, while kisspeptin-10 acts one step upstream on GnRH neurons. This page compares their sequences, place in the reproductive axis, research uses, regulatory and WADA status, and analytical concerns.
Gonadorelin is the synthetic form of gonadotropin-releasing hormone (GnRH), a decapeptide made by hypothalamic neurons that signals the pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). It was previously approved in the US as a diagnostic agent (Factrel) but is no longer marketed there, and it is used in veterinary products.
Kisspeptin-10 is the C-terminal decapeptide of the kisspeptin family. Kisspeptins act on the KISS1 receptor expressed on GnRH neurons and are now regarded as key upstream regulators of GnRH release. Both peptides therefore stimulate the same hormonal cascade but enter it at different levels, which makes them complementary tools in reproductive physiology research.
Side-by-side
| Attribute | Gonadorelin | Kisspeptin-10 |
|---|---|---|
| Origin | Identical to native hypothalamic GnRH | C-terminal 10 residues of kisspeptins derived from the KISS1 gene product |
| Sequence | pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH<sub>2</sub> | Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH<sub>2</sub> |
| Terminal chemistry | N-terminal pyroglutamate; C-terminal glycinamide | Free N-terminus; C-terminal Arg-Phe-amide (RF-amide) |
| Receptor target | GnRH receptor on pituitary gonadotrophs | KISS1R (GPR54) on hypothalamic GnRH neurons |
| Level of action | Pituitary | Hypothalamus (upstream of GnRH) |
| Research areas | Pituitary function testing; reproductive endocrinology; veterinary reproduction | Human reproductive physiology; hypogonadotropic conditions; assisted reproduction research (mostly kisspeptin-54) |
| Evidence level | Previously approved US diagnostic; veterinary use | Early-clinical; small physiology studies |
| FDA status | Previously approved as Factrel, no longer marketed in the US | Not FDA-approved |
| WADA | Prohibited in males under S2 (GnRH analogues) | Check the current WADA Prohibited List |
| Analytical pitfalls | Pyroglutamate formation and confirmation; Trp oxidation; similarity to GnRH analogues | Trp oxidation; Asn deamidation; confusion with longer kisspeptins |
Two levels of the same axis
The reproductive axis runs from hypothalamic neurons to the pituitary to the gonads. Kisspeptin neurons signal to GnRH neurons through KISS1R, GnRH is released in pulses into the pituitary portal circulation, and the pituitary responds with LH and FSH. Gonadorelin bypasses the hypothalamus and stimulates the pituitary directly. Kisspeptin-10 depends on intact GnRH neurons to produce an effect. Comparing responses to the two has been used in human research to locate where a defect lies in conditions with low reproductive hormone levels.
Pulsatility and receptor desensitization
GnRH receptor signaling depends strongly on pattern. Pulsatile GnRH maintains gonadotropin release, while continuous exposure to GnRH or long-acting analogues such as triptorelin desensitizes the receptor and suppresses the axis, the basis for several approved drugs. Kisspeptin signaling can also show desensitization with continuous exposure in experimental studies. These pattern-dependent effects mean that results from one study design cannot be generalized to another, and they are a central consideration when interpreting the research literature on either peptide.
Analytical considerations
Gonadorelin's N-terminal pyroglutamate is formed by cyclization of glutamine or glutamic acid, and mass spectrometry should confirm the cyclized form, since the open-chain precursor has a different mass. Its single tryptophan is oxidation-prone. Kisspeptin-10 contains a tryptophan and two asparagines, so oxidized and deamidated variants should be monitored, and certificates should make clear that the decapeptide rather than kisspeptin-54 or another length was tested. Both are short enough that counter-ion content strongly affects net peptide content.
Frequently asked questions
What is the difference between gonadorelin and kisspeptin-10?
Gonadorelin is synthetic GnRH and acts directly on the pituitary to trigger LH and FSH release. Kisspeptin-10 acts one step earlier, on GnRH neurons in the hypothalamus, causing them to release GnRH. Both are decapeptides with amidated C-termini, but their sequences and receptors are unrelated.
Is gonadorelin FDA approved?
Gonadorelin was previously approved in the US as a diagnostic agent under the name Factrel, but it is no longer marketed there. It remains in use in veterinary products. Kisspeptin-10 has never been FDA-approved and has been used in humans only in research studies. Compounding status for either should be checked against current FDA guidance.
Are gonadorelin and kisspeptin-10 banned in sport?
WADA prohibits GnRH and its analogues, including gonadorelin, in male athletes under class S2, because they can raise testosterone through LH release. For kisspeptin-10, check the current WADA Prohibited List, since the list is updated each year and the status of related releasing factors can change.
Full entries
- Gonadorelin
Gonadorelin is the synthetic form of native gonadotropin-releasing hormone (GnRH), a 10-amino-acid hypothalamic peptide that stimulates release of LH and FSH. It was previously approved in the US as a diagnostic agent and is used in veterinary products.
- Kisspeptin-10
Kisspeptin-10 is the C-terminal decapeptide of kisspeptin, the product of the KISS1 gene. It activates the kisspeptin receptor (KISS1R, also called GPR54) and is studied as a regulator of gonadotropin-releasing hormone and reproductive hormones.
Cite this page